Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE4.0900
- TODAY'S CHANGE (%)-0.1600 (-3.7647%)
- Bid / Lots4.1000/ 2
- Ask / Lots4.1900/ 60
- Open / Previous Close4.2400 / 4.2500
- Day Range
- 52 Week Range
- Volume541,066
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 6106 | 4.2201 |
| 09:34 ET | 100 | 4.22 |
| 09:36 ET | 1510 | 4.23 |
| 09:38 ET | 6219 | 4.1833 |
| 09:39 ET | 3200 | 4.19 |
| 09:43 ET | 100 | 4.2 |
| 09:45 ET | 684 | 4.19 |
| 09:48 ET | 1535 | 4.19 |
| 09:50 ET | 2455 | 4.18 |
| 09:54 ET | 165 | 4.1825 |
| 09:56 ET | 972 | 4.195 |
| 09:57 ET | 3300 | 4.2 |
| 09:59 ET | 200 | 4.21 |
| 10:01 ET | 1700 | 4.2 |
| 10:03 ET | 200 | 4.21 |
| 10:06 ET | 400 | 4.215 |
| 10:08 ET | 100 | 4.21 |
| 10:12 ET | 1300 | 4.22 |
| 10:14 ET | 2351 | 4.24 |
| 10:15 ET | 6227 | 4.225 |
| 10:17 ET | 16511 | 4.215 |
| 10:19 ET | 300 | 4.215 |
| 10:21 ET | 1128 | 4.22 |
| 10:24 ET | 4627 | 4.2106 |
| 10:26 ET | 14588 | 4.2 |
| 10:28 ET | 5527 | 4.175 |
| 10:30 ET | 2850 | 4.175 |
| 10:32 ET | 300 | 4.175 |
| 10:33 ET | 1900 | 4.19 |
| 10:35 ET | 400 | 4.19 |
| 10:37 ET | 1900 | 4.175 |
| 10:39 ET | 1700 | 4.165 |
| 10:42 ET | 200 | 4.14 |
| 10:44 ET | 1812 | 4.145 |
| 10:46 ET | 100 | 4.15 |
| 10:48 ET | 5101 | 4.145 |
| 10:50 ET | 2597 | 4.165 |
| 10:51 ET | 1460 | 4.1692 |
| 10:53 ET | 1601 | 4.165 |
| 10:55 ET | 1770 | 4.16 |
| 10:57 ET | 4695 | 4.15 |
| 11:00 ET | 100 | 4.155 |
| 11:02 ET | 4328 | 4.15 |
| 11:04 ET | 500 | 4.14 |
| 11:06 ET | 10796 | 4.11 |
| 11:08 ET | 400 | 4.11 |
| 11:09 ET | 5783 | 4.11 |
| 11:11 ET | 1550 | 4.1192 |
| 11:13 ET | 300 | 4.11 |
| 11:15 ET | 5634 | 4.13 |
| 11:18 ET | 751 | 4.11 |
| 11:20 ET | 2000 | 4.1101 |
| 11:22 ET | 2800 | 4.11 |
| 11:24 ET | 600 | 4.12 |
| 11:26 ET | 200 | 4.115 |
| 11:27 ET | 300 | 4.115 |
| 11:29 ET | 1608 | 4.11 |
| 11:31 ET | 6906 | 4.11 |
| 11:33 ET | 2990 | 4.08 |
| 11:36 ET | 2691 | 4.07 |
| 11:38 ET | 4105 | 4.075 |
| 11:40 ET | 1200 | 4.1 |
| 11:42 ET | 3421 | 4.115 |
| 11:44 ET | 500 | 4.1064 |
| 11:45 ET | 1639 | 4.105 |
| 11:47 ET | 3250 | 4.105 |
| 11:49 ET | 111 | 4.11 |
| 11:51 ET | 821 | 4.125 |
| 11:54 ET | 4256 | 4.14 |
| 11:58 ET | 1421 | 4.135 |
| 12:00 ET | 5439 | 4.135 |
| 12:02 ET | 4200 | 4.125 |
| 12:05 ET | 5927 | 4.13 |
| 12:07 ET | 400 | 4.12 |
| 12:09 ET | 307 | 4.12 |
| 12:14 ET | 800 | 4.11 |
| 12:18 ET | 5924 | 4.095 |
| 12:20 ET | 2100 | 4.085 |
| 12:21 ET | 600 | 4.0859 |
| 12:23 ET | 100 | 4.085 |
| 12:25 ET | 11601 | 4.095 |
| 12:27 ET | 100 | 4.0966 |
| 12:30 ET | 2018 | 4.08 |
| 12:32 ET | 608 | 4.0666 |
| 12:34 ET | 5900 | 4.065 |
| 12:36 ET | 6450 | 4.065 |
| 12:38 ET | 800 | 4.08 |
| 12:39 ET | 1400 | 4.0792 |
| 12:41 ET | 4806 | 4.085 |
| 12:43 ET | 2369 | 4.08 |
| 12:45 ET | 800 | 4.08 |
| 12:48 ET | 2730 | 4.085 |
| 12:50 ET | 449 | 4.085 |
| 12:52 ET | 504 | 4.0875 |
| 12:56 ET | 250 | 4.085 |
| 12:57 ET | 8373 | 4.065 |
| 12:59 ET | 1000 | 4.0628 |
| 01:01 ET | 2800 | 4.065 |
| 01:03 ET | 7146 | 4.06 |
| 01:06 ET | 8160 | 4.0718 |
| 01:08 ET | 1296 | 4.075 |
| 01:10 ET | 413 | 4.075 |
| 01:12 ET | 1300 | 4.06 |
| 01:14 ET | 100 | 4.06 |
| 01:15 ET | 661 | 4.065 |
| 01:17 ET | 960 | 4.065 |
| 01:19 ET | 3210 | 4.0754 |
| 01:21 ET | 500 | 4.075 |
| 01:24 ET | 2000 | 4.0672 |
| 01:26 ET | 1410 | 4.065 |
| 01:28 ET | 502 | 4.075 |
| 01:30 ET | 5289 | 4.085 |
| 01:32 ET | 2976 | 4.09 |
| 01:33 ET | 1231 | 4.095 |
| 01:37 ET | 200 | 4.095 |
| 01:42 ET | 2607 | 4.1 |
| 01:44 ET | 400 | 4.1 |
| 01:46 ET | 1788 | 4.105 |
| 01:48 ET | 2320 | 4.105 |
| 01:50 ET | 5891 | 4.115 |
| 01:51 ET | 1102 | 4.105 |
| 01:57 ET | 200 | 4.1 |
| 02:00 ET | 210 | 4.11 |
| 02:02 ET | 1063 | 4.105 |
| 02:04 ET | 100 | 4.11 |
| 02:08 ET | 500 | 4.1 |
| 02:13 ET | 100 | 4.1 |
| 02:15 ET | 3610 | 4.11 |
| 02:18 ET | 342 | 4.11 |
| 02:20 ET | 254 | 4.1 |
| 02:22 ET | 700 | 4.105 |
| 02:26 ET | 1000 | 4.1041 |
| 02:31 ET | 100 | 4.1 |
| 02:33 ET | 700 | 4.0901 |
| 02:38 ET | 1019 | 4.1 |
| 02:40 ET | 100 | 4.105 |
| 02:42 ET | 5000 | 4.11 |
| 02:44 ET | 250 | 4.1 |
| 02:45 ET | 863 | 4.1 |
| 02:47 ET | 5905 | 4.115 |
| 02:49 ET | 347 | 4.115 |
| 02:51 ET | 1138 | 4.11 |
| 02:54 ET | 400 | 4.11 |
| 02:56 ET | 8224 | 4.12 |
| 02:58 ET | 141 | 4.11 |
| 03:00 ET | 200 | 4.1 |
| 03:02 ET | 1395 | 4.09 |
| 03:03 ET | 5009 | 4.11 |
| 03:05 ET | 378 | 4.09 |
| 03:07 ET | 950 | 4.095 |
| 03:09 ET | 220 | 4.095 |
| 03:12 ET | 1050 | 4.095 |
| 03:14 ET | 400 | 4.1 |
| 03:16 ET | 5856 | 4.1 |
| 03:18 ET | 11300 | 4.105 |
| 03:20 ET | 6303 | 4.105 |
| 03:23 ET | 600 | 4.1 |
| 03:25 ET | 100 | 4.1 |
| 03:27 ET | 700 | 4.105 |
| 03:30 ET | 400 | 4.105 |
| 03:32 ET | 828 | 4.105 |
| 03:34 ET | 9715 | 4.105 |
| 03:36 ET | 8065 | 4.095 |
| 03:38 ET | 5699 | 4.095 |
| 03:39 ET | 2482 | 4.08 |
| 03:41 ET | 21526 | 4.06 |
| 03:43 ET | 755 | 4.05 |
| 03:45 ET | 20340 | 4.08 |
| 03:48 ET | 5465 | 4.095 |
| 03:50 ET | 600 | 4.1 |
| 03:52 ET | 7354 | 4.09 |
| 03:54 ET | 1076 | 4.085 |
| 03:56 ET | 500 | 4.085 |
| 03:57 ET | 11907 | 4.075 |
| 03:59 ET | 17474 | 4.09 |
Sep 17, 2024
DJ Mereo BioPharma Group Down Over 9%, on Pace for Largest Percent Decrease Since August 2023 -- Data Talk, from 1:42PM ET on Tuesday Sep 17, 2024 by Dow Jones
1:42PM ET on Tuesday Sep 17, 2024 by Dow Jones
Sep 16, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:21PM ET on Monday Sep 16, 2024 by Dow Jones
12:21PM ET on Monday Sep 16, 2024 by Dow Jones
Sep 12, 2024
Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference, from 5:35PM ET on Thursday Sep 12, 2024 by Dow Jones
5:35PM ET on Thursday Sep 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 653.9M | -12.4x | --- |
Immunome Inc | 900.2M | -2.5x | --- |
Applied Therapeutics Inc | 884.3M | -5.1x | --- |
89Bio Inc | 867.4M | -3.9x | --- |
Terns Pharmaceuticals Inc | 845.7M | -7.4x | --- |
Mesoblast Ltd | 804.3M | -7.7x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). In addition to the rare disease programs, it has two oncology product candidates in clinical development. Etigilimab is an IgG1 monoclonal antibody which binds to the human T-cell immunoreceptor with Ig and ITIM domains (TIGIT) receptor on immune cells to improve the activation and effectiveness of T-cell and NK cell antitumor activity. Navicixizumab is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Navicixizumab is developed for the treatment of late line ovarian cancer.
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $653.9M |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 153.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.98 |
EPS | $-0.33 |
Book Value | $0.47 |
P/E Ratio | -12.4x |
Price/Sales (TTM) | 62.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
